[seopress_breadcrumbs]

Episode #104 – We’re Cyborg’s Now, but Here’s What Cyborg’s Will Be in the Future – with Dr. Chris Hables Gray

•

Episode #104 - We’re Cyborg’s Now, but Here’s What Cyborg’s Will Be in the Future - with Dr. Chris Hables Gray — We're Already Cyborgs

Dr. Hables Gray graduated with a PhD in applied philosophy from UCAL Santa Cruz, and is best known for his writings on technology, war, and cyborgs (the combination of organic and inorganic, the evolved and the invented).

In this interview, Dr. Hables Gray explains his ideas around how seemingly mundane technologies and social media help to blur the line between man and machine, as well as his predictions for how far cyborgs will progress in the coming decades (including the integration of drone technology, brain-machine interface, and more).

Click here to listen on Libsyn

Listen on iTunes.

image credit: cyborgphotos.files.wordpress.com

Recommended from Emerj

Read more

Why Architecture Determines the Future of AI Innovation

Enterprises today face a structural information problem. The majority of new business data is unstructured — documents, emails, contracts, and multimedia scattered across fragmented systems. IDC estimates that 90% of the data generated by organizations in 2022 was unstructured. A study by Bar‑Ilan University researchers shows that employees lose meaningful portions of their workweek to…

•

Read more

The Millennium Project: The Business Implications of Global AGI Regulation and Oversight

As geopolitical tensions, economic uncertainty, and rapid advances in frontier AI converge, the governance of Artificial General Intelligence (AGI) has moved from a speculative concern to a central priority for global institutions. Over the past year, leading researchers, including Yoshua Bengio, Stuart Russell, and whistleblowers such as William Saunders, have warned U.S. lawmakers that AGI…

•

Read more

Why Accurate, Real-Time Edge AI Saves Lives in Physical Operations

This interview analysis is sponsored by Motive and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. In industries where seconds matter and margins are thin, delayed feedback, manual processes, and limited visibility make it…

•

Healthcare technology graphic representing Tenet Healthcare’s use of AI for clinical documentation and revenue cycle automation.

Read more

Artificial Intelligence at Tenet Healthcare

Tenet Healthcare Corporation is one of the largest investor-owned healthcare services companies in the United States. Headquartered in Dallas, Texas, the company operates 65 acute care hospitals and over 450 healthcare facilities, including ambulatory surgery centers and other outpatient facilities. As of late 2025, Tenet reported trailing twelve-month revenue of approximately $20.8 billion, a…

•

Read more

Building Compliant AI in a Changing IP Landscape

This interview analysis is sponsored by CCC and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. AI is advancing across enterprise workflows faster than governance frameworks and licensing structures can keep pace. Gaps in…

Matthew DeMello

•

February 25, 2026

Read more

Future GenAI Use Cases for Financial Services

Bankers are flooded with market signals, filings, and global events, yet lack tools to filter out what actually matters for each client, creating information overload that slows decision-making and weakens the impact of advisory. Research from the Boston College Center for Retirement Research shows that as financial complexity rises, investors reduce processing effort, and individuals…

•

February 23, 2026

Read more

Artificial Intelligence at Allianz Two Use Cases

Allianz Group is one of the world's leading insurers and asset managers serving approximately 125 million private and corporate customers across nearly 70 countries. In 2024, the company reported total business volume of $208 billion USD and operating profit of $18.5 billion, per an Allianz media release. Although Allianz does not publicly disclose precise investment…

•

February 14, 2026

Read more

Architecting Enterprise AI for Generative and Agentic Systems – with Ranjan Sinha of IBM

Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm Savanta, found that the average global enterprise wastes more than USD $370 million each year on technical debt. The primary reason for this technical debt cited in the study is that legacy transformation projects…

•

February 9, 2026

Read more

Rethinking How Life Sciences Organizations Approach AI – Mathias Cousin of Deloitte

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Life sciences organizations stand at a paradoxical moment in AI adoption. The technology’s potential is visible in discovery,…

•

February 5, 2026

Read more

Ethical AI Solutions and Their Impact on Regulated Industries

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems that deliver measurable operational improvements. At the same time, they must keep these systems safe, explainable, and aligned with human judgment. Errors in these contexts carry real human and economic consequences. In manufacturing, these…

•

February 2, 2026

Read more

Artificial Intelligence at Bristol Myers Squibb – Two Use Cases

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to delivering innovative medicines across oncology, hematology, immunology, cardiovascular disease, and neuroscience. The company serves patients worldwide through a comprehensive portfolio of breakthrough therapies developed across multiple therapeutic areas. In 2024, Bristol Myers Squibb reported annual revenue of $48.3 billion according to company earnings reports. At…

•

January 26, 2026

Read more

Governing AI while Delivering Business Impact with NLP Logix and TD Bank

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Government and industry leaders increasingly agree that governance is now foundational to AI — not optional — because…

•

January 16, 2026